• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The aromatase enzyme: from cloning to cancer.

作者信息

Simpson E R, Price T, Aitken J, Mahendroo M, Means G, Kilgore M

机构信息

Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235.

出版信息

Princess Takamatsu Symp. 1990;21:75-87.

PMID:2134692
Abstract

Estrogen production by adipose tissue has been implicated in the etiology of such human cancers as endometrial and breast cancer. Estrogen production by adipose cells is subject to complex multifactorial regulation by a number of growth factors and cytokines, including those produced by breast cancer cells. In order to understand the mechanisms responsible for aromatase regulation, the structural gene encoding aromatase cytochrome P-450 (P-450AROM) was isolated from human genomic DNA. The gene spans at least 70 kb and is comprised of 10 exons, the first of which is untranslated. DNA sequence analysis indicates that the gene has a putative TATA (ATAAAA) sequence at -23 bp and putative CAAT binding sequences beginning at -41, -67, and -83 bp, that constitute a promoter region responsible for expression in placenta. However, this promoter does not appear to be responsible for expression in adipose, which may therefore be under the control of another, tissue-specific, promoter. Use of Polymerase Chain Reaction (PCR) technology has allowed for determination of expression of P-450AROM in samples of breast adipose. Preliminary results indicate that expression is highest in the upper lateral region, similar to the site of most frequent localization of tumors.

摘要

相似文献

1
The aromatase enzyme: from cloning to cancer.
Princess Takamatsu Symp. 1990;21:75-87.
2
Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta.人P-450芳香化酶的组织特异性表达。负责在脂肪组织中表达的启动子与胎盘所利用的启动子不同。
J Biol Chem. 1991 Jun 15;266(17):11276-81.
3
Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis.编码人芳香化酶细胞色素P-450的基因的结构分析,该酶负责雌激素的生物合成。
J Biol Chem. 1989 Nov 15;264(32):19385-91.
4
Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.人类CYP19(芳香化酶P450)基因新型内皮启动子的克隆与特性分析,该启动子在乳腺癌组织中上调。
Mol Endocrinol. 2002 Oct;16(10):2243-54. doi: 10.1210/me.2002-0123.
5
Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.利用替代启动子在无癌患者和乳腺癌患者的乳腺脂肪组织中表达芳香化酶细胞色素P450(CYP19)基因。
J Clin Endocrinol Metab. 1996 Nov;81(11):3843-9. doi: 10.1210/jcem.81.11.8923826.
6
Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.人类CYP19(芳香化酶)基因序列的特征分析,该基因序列介导脂肪基质细胞和胎儿肝细胞中糖皮质激素的调控作用。
Mol Endocrinol. 1995 Mar;9(3):340-9. doi: 10.1210/mend.9.3.7776980.
7
Use of molecular probes to study regulation of aromatase cytochrome P-450.
Biol Reprod. 1990 Jan;42(1):1-10. doi: 10.1095/biolreprod42.1.1.
8
Alternative promotion of aromatase P-450 expression in the human placenta.
Mol Cell Endocrinol. 1992 Jan;83(1):R9-16. doi: 10.1016/0303-7207(92)90202-h.
9
Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues.组织特异性启动子调控人卵巢和胎儿组织中芳香化酶细胞色素P450基因的表达。
Mol Endocrinol. 1991 Dec;5(12):2005-13. doi: 10.1210/mend-5-12-2005.
10
Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.水牛卵巢和胎盘中CYP19基因表达的不同启动子使用情况。
Gen Comp Endocrinol. 2009 Jul;162(3):319-28. doi: 10.1016/j.ygcen.2009.04.009. Epub 2009 Apr 16.